Two-Colour Fluorescence Marker for Neurodegenerative Diseases
Worldwide it is estimated that there are 29 million cases of Alzheimer Disease (AD) and about 4 million of Parkinson's Disease (PD). The world market for AD and PD is estimated to be 14 billion dollars corresponding to an annual growth rate of 20%, making it an very attractive field for R&D to generate novel therapeuticals. Recently, the accumulation of dysfunctional mitochondria has been linked to neurodegenerative diseases, in particular to AD and PD. Scientists at the University of Göttingen have developed a powerful fluorescent marker for Live Cell Imaging to study mitochondrial dysfunctions and for testing novel pharmaceutical products
Further Information: PDF
MBM ScienceBridge GmbH
Phone: (0551) 30724-152
Contact
Dr. Jens-Peter Horst
Media Contact
All latest news from the category: Technology Offerings
Newest articles
Microscopic basis of a new form of quantum magnetism
Not all magnets are the same. When we think of magnetism, we often think of magnets that stick to a refrigerator’s door. For these types of magnets, the electronic interactions…
An epigenome editing toolkit to dissect the mechanisms of gene regulation
A study from the Hackett group at EMBL Rome led to the development of a powerful epigenetic editing technology, which unlocks the ability to precisely program chromatin modifications. Understanding how…
NASA selects UF mission to better track the Earth’s water and ice
NASA has selected a team of University of Florida aerospace engineers to pursue a groundbreaking $12 million mission aimed at improving the way we track changes in Earth’s structures, such…
